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Abstract
Background: The infectious dose required to infect mosquito vectors when they take a blood meal from a viremic person is
a critical parameter underlying the probability of dengue virus (DENV) transmission. Because experimental vector
competence studies typically examine the proportion of mosquitoes that become infected at intermediate or high DENV
infectious doses in the blood meal, the minimum blood meal titer required to infect mosquitoes is poorly documented.
Understanding the factors influencing the lower infectiousness threshold is epidemiologically significant because it
determines the transmission potential of humans with a low DENV viremia, possibly including inapparent infections, and
during the onset and resolution of the viremic period of acutely infected individuals.
Methodology/Principal Findings: We compared the susceptibility of two field-derived Aedes aegypti populations from
Kamphaeng Phet, Thailand when they were orally exposed to low titers of six DENV-2 isolates derived from the serum of
naturally infected humans living in the same region. The infectious dose, time-point post-blood feeding, viral isolate and
mosquito population, were significant predictors of the proportion of mosquitoes that became infected. Importantly, the
dose-response profile differed significantly between the two Ae. aegypti populations. Although both mosquito populations
had a similar 50% oral infectious dose (OID50), the slope of the dose-response was shallower in one population, resulting in a
markedly higher susceptibility at low blood meal titers.
Conclusions/Significance: Our results indicate that mosquitoes in nature vary in their infectious dose-response to DENV.
Thus, different mosquito populations have a differential ability to acquire DENV infection at low viremia levels. Future
studies on human-to-mosquito DENV transmission should not be limited to OID50 values, but rather they should be
expanded to account for the shape of the dose-response profile across a range of virus titers.
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Introduction
Recent estimations bring to almost 400 million the number of
human dengue virus (DENV) infections that occur worldwide each
year, of which about three quarters are expected to be clinically
inapparent [1]. Dengue is a self-limiting infection caused by RNA
viruses of the genus Flavivirus that are transmitted among humans
by mosquitoes [2]. DENV include four serotypes (DENV-1, -2, -3
and -4) that are phylogenetically closely related, but antigenically
distinct. The principal mosquito vector species of DENV
worldwide is Aedes aegypti, although Ae. albopictus has occasionally
been implicated in relatively small-scale dengue outbreaks [3].
Currently, there is no licensed vaccine or commercially available
therapeutic for dengue. Disease prevention relies on the control of
mosquito vector populations. Transmission occurs when a
mosquito bites a human during their viremic period, which
typically lasts 4–5 days [4–6]. On average, the probability of
DENV transmission from symptomatic humans to mosquitoes
follows the kinetics of viremia [7], from as soon as two days before
the onset of fever to the day following defervescence [8].
One critical parameter underlying a successful human-to-
mosquito DENV transmission event is the magnitude of human
viremia required to infect mosquitoes. It is well established that the
proportion of infected mosquitoes is positively associated with the
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virus dose ingested in artificial blood meals [9,10]. The dose-
response of mosquitoes generally follows a sigmoid relationship
with 0% infection below a lower threshold and 100% infection
above an upper threshold. A recent study documented the dose-
response of Ae. aegypti fed directly on the blood from clinically ill,
naturally infected humans in Vietnam [7]. Analysis of the
proportion of infected mosquitoes as a function of human plasma
viremia confirmed the sigmoid shape of the mosquito dose-
response. There was no or little transmission below 103 viral RNA
copies/ml of plasma, and close to 100% transmission above 109
viral RNA copies/ml. Estimates for the 50% oral infectious dose
(OID50), defined as the virus concentration resulting in 50%
infected mosquitoes, ranged from 106.29 to 107.52 viral RNA
copies/ml of plasma [7]. Interestingly, the OID50 differed among
serotypes, indicating that viral factors influence the shape of the
mosquito dose-response.
Most vector competence studies use blood meal titers that are in
the higher part of the mosquito dose-response to DENV (e.g., [11–
14]). In other words, virus titers in blood meals are typically
around or greater than the OID50. The lower part of the dose-
response (i.e., mosquito infection rates ,50%) has generally not
been examined, perhaps because vector-virus interaction studies
need to maximize the number of infected mosquitoes. Gaining a
better understanding of the lower part of the dose-response to
DENV is epidemiologically important for at least three reasons.
First, epidemic DENV transmission is not always associated with
high human viremias [15,16]. Second, even when peak viremia is
high, there are periods of low viremia during the onset and
resolution of the viremic period that may contribute to human-to-
mosquito DENV transmission. Third, understanding infectious-
ness to mosquitoes at low viremia levels is important to quantify
the potential contribution of people with mild or clinically
inapparent infections to overall DENV transmission. Inapparent
and mild DENV infections are assumed to be associated with
lower viremia levels by extrapolating the positive relationship
observed between viremia and disease severity in symptomatic
human cases [7,17–19]. The contribution of mild human
infections to DENV transmission may be epidemiologically
underappreciated because they have not been studied and they
tend to outnumber the more severe infections that make up the
bulk of the cases detected and studied by public health systems
[1,20,21].
Here, we investigated the susceptibility of two field-derived Ae.
aegypti populations that were orally exposed to low infectious doses
of six low-passage DENV-2 isolates obtained from human serum
samples. All experiments were carried out using the first
laboratory-reared generation of mosquitoes derived from wild
Ae. aegypti collected in Na Bo Kham (NB) and Nakhon Chum (NC),
two villages located approximately 25 km apart in Kamphaeng
Phet Province, Thailand. Our results indicate that dose-response
differed between the two mosquito populations, with one
population being more susceptible to DENV infection at low
infectious doses despite a similar OID50.
Materials and Methods
Mosquitoes
Wild Ae. aegypti immatures (larvae and pupae) were collected
from a variety of artificial containers in several households in Na
Bo Kham (NB) and Nakhon Chum (NC) sub-districts, Muang
district, Kamphaeng Phet Province, Thailand during December
2011 (experiment 1) and August 2012 (experiment 2). F0 adults
were allowed to emerge in the laboratory, mate randomly, and
feed on defibrinated sheep blood (National Laboratory Animal
Center, Mahidol University, Nakhon Pathom, Thailand) through
a membrane feeding system. F1 eggs were collected on paper towel
lining oviposition cups and stored under high humidity. Prior to
the experiments, they were hatched synchronously by placing
them under low pressure for 30 min. Larvae were reared in
2463469 cm plastic trays filled with 2.0 liters of dechlorinated tap
water at a density of approximately 200 first instars per tray and
fed a standard diet of approximately 1.0 g of fish food pellets (C.P.
Hi Pro, Perfect Companion Group Co. Ltd, Bangkok, Thailand)
per tray. After emergence, F1 adults were housed in plastic
30630630 cm cages (Megaview Science Education Service Co.
Ltd, Taichung, Taiwan) with permanent access to 10% sucrose.
They were maintained under insectary conditions at 2861uC,
80% humidity, and with a 12:12 hour light:dark cycle.
Virus isolates
Six DENV-2 isolates (designated as 29, 50, 51, 54, 66, and 67)
were derived from serum samples obtained between July and
September 2010 from people with acute dengue infections in
Nakhon Chum (isolates 29, 50, 51), Sa Kaeo (isolate 54) and Na
Bo Kham (isolates 66, 67). These villages are located 25–35 km
apart in Muang district, Kamphaeng Phet Province, Thailand.
The serum samples were obtained as part of larger geographic
cluster investigations initiated from ‘index’ cases admitted to the
Kamphaeng Phet Provincial Hospital with DENV infections
confirmed by RT-PCR. The study site and cluster investigation
methodology have been described previously [22]. Virus isolation
and identification was performed according to published methods
[23]. Phylogenetic analysis based on their complete envelope gene
sequence assigned the viruses to the Asian genotype II of DENV-2
(data not shown). Each isolate was passaged four times in Ae.
albopictus cells (C6/36, ATCC CRL-1660) prior to its use in
experimental infections of mosquitoes.
Ethics statement
The study protocol was approved by the Institutional Review
Boards of the Thai Ministry of Public Health, Walter Reed Army
Institute of Research, and University of California at Davis.
Written informed consent was obtained from study participants
and/or parents of participants; assent was obtained from persons
more than seven years of age.
Oral challenge
Experimental infections were conducted as previously described
[24]. Briefly, two sets of two-day-old confluent cultures of C6/36
cells in 25 cm2 flasks (approximately 107 cells/flask) were inocu-
lated with 1.0 ml of stock virus per flask and incubated at 35uC.
Supernatant was harvested five days post-inoculation to prepare
the infectious blood meal. The artificial blood meal consisted of
1:1 mix of defibrinated sheep blood (National Laboratory Animal
Center, Mahidol University, Nakhon Pathom, Thailand) and virus
suspension. Three infectious doses were prepared by using the
viral supernatant undiluted, diluted 0.5 and diluted 0.1 in RPMI
1640 medium with 5% heat-inactivated fetal bovine serum
(HIFBS). Four- to seven-day-old Ae. aegypti F1 females deprived
of sucrose and water for 24 hours were offered an infectious blood
meal for 30 min through pieces of desalted porcine intestine
stretched over water-jacketed glass feeders maintained at 37uC.
Samples of the blood meals were saved for subsequent titration by
plaque assay. After blood feeding, mosquitoes were briefly sedated
with CO2 from dry ice and fully engorged females were transferred
to clean paper cups. Unfed or partially fed females were discarded.
Engorged females were maintained under standard insectary
Mosquito Susceptibility to Low Dengue Virus Doses
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conditions, as described above, and provided cotton soaked with
10% sucrose ad libitum.
Susceptibility
Infection of Ae. aegypti midguts by the six DENV-2 isolates was
assessed for the three infectious doses at 7 and 14 days post-blood
feeding based on the proportion of infected mosquitoes deter-
mined by plaque assay. Upon harvest, mosquito bodies were kept
individually in 1.0 ml of mosquito diluent (MD), consisting of
RPMI 1640 medium with 10% HIFBS with 100 units/ml
penicillin and 100 mg/ml streptomycin. Samples were stored at
270uC before processing. They were quickly thawed in a water
bath at 3562uC and homogenized in a mixer mill (Qiagen,
Hilden, Germany) at 24 cycles/sec for 2 min. Plaque assay was
performed in rhesus monkey kidney cells (LLC-MK2, ATCC
CCL-7) as previously described [25]. Briefly, the homogenized
samples were passed individually through a 0.22 mm syringe filter
unit and 0.5 and 0.1 dilutions were prepared in MD. The samples
were placed in an ice bath and 100 ml/well were inoculated into a
monolayer of LLC-MK2 cells in 24-well plates. The virus was
adsorbed for 1 hour at room temperature (20–28uC) on a rocker
platform. The inoculum was removed and 0.5 ml/well of a first
overlay of medium was added. The cells were incubated for 5 days
at 3561uC in a 560.5% CO2 incubator. The cells were stained
with a second overlay of medium containing 4% neutral red
(Sigma, St. Louis, USA). Plaques were counted and plaque
forming units (PFU)/ml were calculated.
Data analysis
The study was run in two separate experiments that involved
two different sets of DENV isolates and used populations of Ae.
aegypti that were sampled from the same locations, but on different
dates. The isolate and population effects, therefore, were nested
within the effect of the experiment. The proportion of mosquitoes
that became infected following the infectious blood meal was
analyzed with a multifactorial logistic regression that included the
effects of experiment, time-point post-blood feeding, infectious
dose (log10-transformed), mosquito population, viral isolate, and
their interactions up to the second-order. An initial analysis with
third-order interactions showed that none of the third-order terms
had a significant effect. In the models, each mosquito was
represented by a single binary value (0 = uninfected; 1= infected)
so that individual variation was accounted for. Estimates of odds
ratios and their standard errors were obtained with a separate
logistic fit of infection status as a function of infectious dose for
each combination of time-point, isolate and population. The same
logistic fit was used to derive OID50 and OID10 values and their
95% confidence intervals. All analyses were performed with the
software JMP v10.0.2.
Results
A total of 769 Ae. aegypti females were examined for DENV
infection by plaque assay, of which 363 (47.2%) were tested at 7
days post-blood feeding (pbf), and 406 (52.8%) at 14 days pbf. The
two mosquito populations (referred to as NB and NC here after)
were exposed to dilutions of six DENV-2 isolates (experiment 1:
isolates 29, 54, 66 and 67; experiment 2: isolates 50 and 51).
Among isolates, infectious doses were distributed from 103.74 to
105.74 PFU/ml in each blood meal (median 104.74 PFU/ml). Each
combination of mosquito population, virus isolate, and infectious
dose was represented by 6–37 mosquitoes (median 19.5).
Distribution of sample sizes is given in Table S1. One dose was
missing for pairs 54-NB and 67-NB at 7 and 14 days pbf,
respectively.
Overall, 76 (20.9%) of the mosquitoes had detectable infections
at 7 days pbf, and 129 (31.8%) at 14 days pbf. The difference in
the proportion of infected mosquitoes between the two time-points
was statistically significant (Table 1). The average viral titer in
infected bodies (across infectious doses) was 102.41 PFU/ml at 7
days pbf versus 103.02 PFU/ml at 14 days pbf. The strongest effect
influencing the proportion of mosquitoes that became infected
following the infectious blood meal was infectious dose (Table 1).
In general, the percentage of infected mosquitoes strongly
increased with increasing dose (Fig. 1). In addition, there was a
statistically significant interaction between the mosquito popula-
tion and the virus isolate (Table 1), indicating that infection
probability was partly determined by the specific pairing of
mosquito and virus strains. There was no evidence for a
differential effect of mosquito-virus pairs from the same or a
different geographical location.
There was also a highly significant effect of the interaction
between the infectious dose and the mosquito population (Table 1).
This effect reflected a different shape of the dose-response profile
between the two mosquito populations. Across isolates, the dose-
response of the NC population was the typical sigmoid relationship
with a steep exponential phase. The NB population displayed a
shallower dose-response (Fig. 1). The difference was more obvious
at 14 (Fig. 1B) than 7 days pbf (Fig. 1A).
The difference in the overall shape of the dose-response
between the two mosquito populations was further analyzed with
various metrics derived from the logistic fits of the data. The 50%
oral infectious dose (OID50) varied among virus isolates, but was
almost identical between the two mosquito populations both at 7
(Fig. 2A) and 14 days pbf (Fig. 2D). For most isolates, however, the
10% oral infectious dose (OID10) estimates were lower at 14 days
pbf for the NB population compared to the NC population
(Fig. 2E), supporting the conclusion that the NB population is
more susceptible than the NC population to low doses of DENV.
This difference was not apparent at 7 days pbf (Fig. 2B). Likewise,
the odds ratio of the prevalence-dose relationship was always
higher for the NC population at 14 (Fig. 2F), but not 7 days pbf
(Fig. 2C). In this case, the odds ratio describes the relative increase
in prevalence for a one-unit increase in infectious dose. Higher
odds ratio reflect the stronger correlation (i.e., steeper sigmoid)
between the proportion of infected mosquitoes and the blood meal
titer for the NC population than for the NB population.
Discussion
We carried out experimental infections of mosquitoes at the
lower part of their dose-response to DENV. A recent estimate of
DENV-2 OID50 measured 12 days after the infectious blood meal
in Ae. aegypti was 106.29 viral RNA copies/ml of plasma [7]. Based
on their calibration of the quantitative RT-PCR assay used to
measure plasma viremia levels, Nguyen et al. [7] estimated that
106.29 DENV-2 genome copies/ml were equivalent to
104.43 PFU/ml of plasma. Blood meal titers in our experiments
ranged from 103.74 to 105.74 PFU/ml of blood, thus bracketing the
previously reported OID50 value for DENV-2. Accordingly, we
observed an infection prevalence ranging from 0% to 75% among
population-isolate-dose combinations (Fig. 1). We chose to use
plaque assay rather than a more sensitive quantitative RT-PCR
assay because viral RNA concentration does not directly translate
into infectious titer [26]. Fourteen days after the infectious blood
meal, virus in the bodies of mosquitoes with an established DENV
Mosquito Susceptibility to Low Dengue Virus Doses
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infection is expected to have reached infectious titers largely
exceeding the plaque assay detection threshold (10 PFU/ml).
Our results support the idea that wild type Ae. aegypti vary in
their infectious dose-response to oral DENV challenge. Because
environmental conditions were controlled in our experiments, we
interpret phenotypic differences observed between NB and NC
populations as genetic. A previous study reported that Ae. aegypti
populations sampled within 25 km of each other in Thailand,
including the Kamphaeng Phet area, were genetically differenti-
ated [27]. Elucidating the genetic factors responsible for the higher
susceptibility of the NB population at a low infectious dose
compared to the NC population may provide greater insight into
the genetic basis of vector competence. Although there was
considerable variation in infection prevalence among the six low-
passage DENV-2 isolates (OID50 values ranged from 10
4.61 to
106.02 PFU/ml at 14 days pbf), we observed that the overall shape
of the dose-response profile of both Ae. aegypti populations was
consistent across isolates. In particular, odds ratios of the
prevalence-dose relationship estimated at 14 days pbf were always
higher for the NC population than for the NB population (Fig. 2F),
as illustrated by the steeper slope of the central part of the sigmoid
relationship. This indicates that the overall shape of the dose-
response is an intrinsic feature of the mosquito population that
transcends specific interactions that have been reported to occur
between mosquito and virus genotypes [28].
We examined only two Ae. aegypti populations and a limited set
of DENV-2 isolates of the Asian genotype II. Additional studies
are necessary to determine whether our conclusions can be
extrapolated to other mosquito populations and virus genotypes.
Here, we provide proof-of-principle that variation in dose-
response may exist among mosquito populations and should be
considered in the design of future studies. Although individual
Figure 1. Logistic fits of the observed dose-responses. The percentage of mosquitoes found virus-positive 7 days (A) and 14 days (B) after oral
challenge is shown as a function of the blood meal titer for all combinations of two Ae. aegypti populations (NB= Na Bo Kham; NC= Nakhon Chum)
and six DENV-2 virus isolates (experiment 1: isolates 29, 54, 66 and 67; experiment 2: isolates 50 and 51). Symbols represent empirical data and lines
are logistic fits of the data. Solid symbols and lines correspond to the NB population; Open symbols and dashed lines represent the NC population.
Note that the logistic fit of the 51-NB pair at day 14 was omitted from the figure because parameter estimates were unstable.
doi:10.1371/journal.pone.0092971.g001
Table 1. Multifactorial logistic regression of infection status.
Source df L-R x2 P-value
Experiment 1 12.3 0.0005
Time-point 1 11.5 0.0007
Experiment*Time-point 1 0.92 0.3386
Dose 1 61.3 ,0.0001
Experiment*Dose 1 1.06 0.3041
Time-point*Dose 1 2.62 0.1054
Isolate [within Experiment] 4 22.5 0.0002
Population [within Experiment] 2 9.51 0.0086
Isolate*Time-point [within Experiment] 4 5.55 0.2352
Isolate*Population [within Experiment] 4 17.2 0.0018
Isolate*Dose [within Experiment] 4 2.18 0.7026
Population*Time-point [within Experiment] 2 0.90 0.6390
Population*Dose [within Experiment] 2 11.8 0.0027
Significant P-values (,0.05) are in bold. df: degrees of freedom; L-R: likelihood ratio.
doi:10.1371/journal.pone.0092971.t001
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dose-responses curves of some population-isolate pairs lacked
accuracy because of relatively small sample sizes (Table S1), the
interaction between mosquito population and infectious dose was
statistically significant across population-isolate pairs. In other
words, the overall effect was robustly supported by larger sample
sizes than those obtained for each population-isolate pair.
Differences in the ability of vector populations to acquire
DENV infection at low blood meal titers may help to explain some
puzzling aspects of dengue epidemiology. For example, this
process may have contributed to rare instances of epidemic
DENV transmission associated with low viremia in humans
[15,16]. Variation in the ability of mosquito populations to acquire
DENV infection at low viremia levels also may result in
heterogeneities in the potential contribution of people with mild
dengue infections to overall DENV transmission. Assuming that
inapparent/mild DENV infections are associated with lower
viremias [7,17–19], their epidemiological significance may depend
on the local mosquito population with which they interact.
A caveat of our study is that we focused on mosquito infection
prevalence and did not consider virus dissemination from the
midgut to other tissues and, thus, the potential for transmission
(i.e., vector competence). Because the blood meal titers were
relatively low, the numbers of mosquitoes that developed a
disseminated infection in head tissues (data not shown) were too
small for a meaningful analysis. Infection of the mosquito midgut is
a critical prerequisite for transmission via mosquito bite [29].
Whether our conclusions hold for actual mosquito-to-human
DENV transmission requires additional investigation. When
possible, in future studies we recommend that investigators try to
move away from artificial mosquito feedings methods by including
more natural conditions of DENV transmission [30]. A recent
study conducted in Vietnam [7] has set a higher standard for
human-to-mosquito transmission experiments and highlighted the
shortcomings of artificial blood meals. For example, DENV-
reactive antibody levels in human plasma samples were negatively
correlated with the probability of virus transmission by mosqui-
toes, independently of viremia level [7]. Such immunological
factors are not accounted for in artificial infectious blood meals.
One important implication of our results is that a single
summary metric, such as the OID50, is not sufficient to describe
the complexity of mosquito-virus interactions that underlies
mosquito susceptibility to DENV infection and, perhaps, mosqui-
to-virus interactions in general. Indeed, Ae. aegypti populations in
NB and NC had similar OID50 values, yet their susceptibilities to
Figure 2. Dose-responses differ between the two Ae. aegypti populations. For both Ae. aegypti populations (blue squares: Na Bo Kham [NB];
red circles: Nakhon Chum [NC]), OID50 values (A, D), OID10 values (B, E) and estimated odds ratios (C, F) are shown for each of the six DENV-2 virus
isolates. Upper panels (A–C) correspond to 7 days and lower panels (D–F) to 14 days after the infectious blood meal. Vertical bars indicate 95%
confidence intervals of the OID values and standard errors of the odds ratios. Missing error bars mean that they could not be reliably estimated.
doi:10.1371/journal.pone.0092971.g002
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DENV at a low infectious dose were significantly different. We
recommend, therefore, that in the future investigators studying
human-to-mosquito DENV transmission consider the entire
infectious dose-response profile.
Supporting Information
Table S1 Sample sizes. For each combination of mosquito
population, virus isolate and infectious dose, the number of
individual mosquitoes assayed (N) is indicated.
(DOC)
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